Sanofi
SNY
$46.30
Share price
2.00%
Change (1 day)
-16.91%
Change (1 year)
Categories
Sanofi is a French pharmaceutical company created in 2004 by the merger of Sanofi-Synthélabo and Aventis. With sales of EUR 36.1 billion in 2019 and more than 100,000 employees worldwide, Sanofi is one of the largest pharmaceutical companies in the world in terms of sales.
Number of shares outstanding for Sanofi (SNY)
Number of shares outstanding as of April 2024 : 2,507,200,000
According to Sanofi's latest financial reports and stock price the company's current number of shares outstanding is 2,507,200,000. At the end of 2023 the company had 2,507,200,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Sanofi from 2002 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 2.50 B | -0.03% |
| 2022 | 2.50 B | -0.07% |
| 2021 | 2.50 B | -0.02% |
| 2020 | 2.51 B | 0.16% |
| 2019 | 2.50 B | 0.6% |
| 2018 | 2.49 B | -0.58% |
| 2017 | 2.50 B | -2.34% |
| 2016 | 2.56 B | -1.69% |
| 2015 | 2.60 B | -0.83% |
| 2014 | 2.63 B | -0.4% |
| 2013 | 2.64 B | 0.02% |
| 2012 | 2.64 B | -1.38% |
| 2011 | 2.67 B | 2.39% |
| 2010 | 2.61 B | 0.19% |
| 2009 | 2.61 B | 0.07% |
| 2008 | 2.60 B | -2.56% |
| 2007 | 2.67 B | -1.12% |
| 2006 | 2.70 B | 1.28% |
| 2005 | 2.67 B | 92.03% |
| 2004 | 1.39 B | -1.39% |
| 2003 | 1.41 B | -1.98% |
| 2002 | 1.44 B |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 2,407,200,000 | -3.99% | 🇺🇸 USA |
 Novartis NVS | 2,062,000,000 | -17.76% | 🇨🇭 Switzerland |
 Pfizer PFE | 5,647,000,000 | 125.23% | 🇺🇸 USA |
 Novo Nordisk NVO | 4,476,900,000 | 78.56% | 🇩🇰 Denmark |
 Abbott Laboratories ABT | 1,734,076,358 | -30.84% | 🇺🇸 USA |
 Eli Lilly LLY | 949,379,000 | -62.13% | 🇺🇸 USA |
 Merck MRK | 2,554,166,667 | 1.87% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2,057,000,000 | -17.96% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2,028,000,000 | -19.11% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | 1,121,000,000 | -55.29% | 🇮🇱 Israel |